← golden set
GOOGL
Alphabet Inc.Technologyanswer key
| field | SEC value | XBRL concept | printed on |
|---|---|---|---|
| Total revenue | $402.8B | Revenues | Revenues |
| Operating income | $129.0B | OperatingIncomeLoss | Income from operations |
| Net income attributable to the company | $132.2B | NetIncomeLoss | Net income |
| Diluted EPS | $10.81 | EarningsPerShareDiluted | Diluted net income per share (Note 12) |
| Cash and cash equivalents | $30.7B | CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents |
| Total assets | $595.3B | Assets | Total assets · Total liabilities and stockholders’ equity |
| Total liabilities | $180.0B | Liabilities | Total liabilities |
| Total shareholders' equity attributable to the company | $415.3B | StockholdersEquity | Total stockholders’ equity |
| Net cash from operating activities | $164.7B | NetCashProvidedByUsedInOperatingActivities | Net cash provided by operating activities |
| Net cash from investing activities | -$120.3B | NetCashProvidedByUsedInInvestingActivities | Net cash used in investing activities |
| Net cash from financing activities | -$37.4B | NetCashProvidedByUsedInFinancingActivities | Net cash used in financing activities |
Income statement
table #75 · score 48.5 vs 23.5 runner-up · in millions| Year Ended December 31, | |||
| 2023 | 2024 | 2025 | |
| Revenues | 307,394 | 350,018 | 402,836 |
| Costs and expenses: | |||
| Cost of revenues | 133,332 | 146,306 | 162,535 |
| Research and development | 45,427 | 49,326 | 61,087 |
| Sales and marketing | 27,917 | 27,808 | 28,693 |
| General and administrative | 16,425 | 14,188 | 21,482 |
| Total costs and expenses | 223,101 | 237,628 | 273,797 |
| Income from operations | 84,293 | 112,390 | 129,039 |
| Other income (expense), net | 1,424 | 7,425 | 29,787 |
| Income before income taxes | 85,717 | 119,815 | 158,826 |
| Provision for income taxes | 11,922 | 19,697 | 26,656 |
| Net income | 73,795 | 100,118 | 132,170 |
| Basic net income per share (Note 12) | 5.84 | 8.13 | 10.91 |
| Diluted net income per share (Note 12) | 5.80 | 8.04 | 10.81 |
Balance sheet
table #73 · score 52.8 vs 8.8 runner-up · in millions| As of December 31, | ||
| 2024 | 2025 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 23,466 | 30,708 |
| Marketable securities | 72,191 | 96,135 |
| Total cash, cash equivalents, and marketable securities | 95,657 | 126,843 |
| Accounts receivable, net | 52,340 | 62,886 |
| Other current assets | 15,714 | 16,309 |
| Total current assets | 163,711 | 206,038 |
| Non-marketable securities | 37,982 | 68,687 |
| Deferred income taxes | 17,180 | 9,113 |
| Property and equipment, net | 171,036 | 246,597 |
| Operating lease assets | 13,588 | 15,221 |
| Goodwill | 31,885 | 33,380 |
| Other non-current assets | 14,874 | 16,245 |
| Total assets | 450,256 | 595,281 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | 7,987 | 12,200 |
| Accrued compensation and benefits | 15,069 | 17,546 |
| Accrued expenses and other current liabilities | 51,228 | 55,557 |
| Accrued revenue share | 9,802 | 10,864 |
| Deferred revenue | 5,036 | 6,578 |
| Total current liabilities | 89,122 | 102,745 |
| Long-term debt | 10,883 | 46,547 |
| Income taxes payable, non-current | 8,782 | 9,531 |
| Operating lease liabilities | 11,691 | 12,744 |
| Other long-term liabilities | 4,694 | 8,449 |
| Total liabilities | 125,172 | 180,016 |
| Commitments and Contingencies (Note 10) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value per share, 100 shares authorized; no shares issued and outstanding | 0 | 0 |
| Class A, Class B, and Class C stock and additional paid-in capital, $0.001 par value per share: 300,000 shares authorized (Class A 180,000, Class B 60,000, Class C 60,000); 12,211 (Class A 5,835, Class B 861, Class C 5,515) and 12,088 (Class A 5,822, Class B 837, Class C 5,429) shares issued and outstanding | 84,800 | 93,126 |
| Accumulated other comprehensive income (loss) | (4,800) | (1,916) |
| Retained earnings | 245,084 | 324,055 |
| Total stockholders’ equity | 325,084 | 415,265 |
| Total liabilities and stockholders’ equity | 450,256 | 595,281 |
Cash flow statement
table #81 · score 53.8 vs 7.8 runner-up · in millions| Year Ended December 31, | |||
| 2023 | 2024 | 2025 | |
| Operating activities | |||
| Net income | 73,795 | 100,118 | 132,170 |
| Adjustments: | |||
| Depreciation of property and equipment | 11,946 | 15,311 | 21,136 |
| Stock-based compensation expense | 22,460 | 22,785 | 24,953 |
| Deferred income taxes | (7,763) | (5,257) | 8,348 |
| Loss (gain) on debt and equity securities, net | 823 | (2,671) | (24,620) |
| Other | 4,330 | 3,419 | 2,108 |
| Changes in assets and liabilities, net of effects of acquisitions: | |||
| Accounts receivable, net | (7,833) | (5,891) | (8,779) |
| Income taxes, net | 523 | (2,418) | (3,226) |
| Other assets | (2,143) | (1,397) | (4,542) |
| Accounts payable | 664 | 359 | 907 |
| Accrued expenses and other liabilities | 3,937 | (1,161) | 12,939 |
| Accrued revenue share | 482 | 1,059 | 899 |
| Deferred revenue | 525 | 1,043 | 2,420 |
| Net cash provided by operating activities | 101,746 | 125,299 | 164,713 |
| Investing activities | |||
| Purchases of property and equipment | (32,251) | (52,535) | (91,447) |
| Purchases of marketable securities | (77,858) | (86,679) | (103,773) |
| Maturities and sales of marketable securities | 86,672 | 103,428 | 83,240 |
| Purchases of non-marketable securities | (3,027) | (5,034) | (5,716) |
| Maturities and sales of non-marketable securities | 947 | 882 | 1,367 |
| Acquisitions, net of cash acquired, and purchases of intangible assets | (495) | (2,931) | (1,592) |
| Other investing activities | (1,051) | (2,667) | (2,370) |
| Net cash used in investing activities | (27,063) | (45,536) | (120,291) |
| Financing activities | |||
| Net payments related to stock-based award activities | (9,837) | (12,190) | (14,167) |
| Repurchases of stock | (61,504) | (62,222) | (45,709) |
| Dividend payments | 0 | (7,363) | (10,049) |
| Proceeds from issuance of debt, net of costs | 10,790 | 13,589 | 64,564 |
| Repayments of debt | (11,550) | (12,701) | (32,427) |
| Proceeds from sale of interest in consolidated entities, net | 8 | 1,154 | 400 |
| Net cash used in financing activities | (72,093) | (79,733) | (37,388) |
| Effect of exchange rate changes on cash and cash equivalents | (421) | (612) | 208 |
| Net increase (decrease) in cash and cash equivalents | 2,169 | (582) | 7,242 |
| Cash and cash equivalents at beginning of period | 21,879 | 24,048 | 23,466 |
| Cash and cash equivalents at end of period | 24,048 | 23,466 | 30,708 |
| Supplemental disclosures of non-cash investing activities: | |||
| Purchases of property and equipment included in accrued liabilities and accounts payable | 7,435 | 10,326 | 15,090 |